U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Links from GEO Profiles

Full record GDS5275

Oral ruxolinitib effect on alopecia areata patients: scalp skin

Analysis of scalp skin from two alopecia areata (AA) patients treated with oral ruxolitinib for 12 weeks. AA is a T-cell mediated autoimmune disease. Ruxolitinib is a small-molecule inhibitor of the JAK1/2 kinases. Results provide insight into molecular mechanisms underlying the pathogenesis of AA.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 2 agent, 2 disease state, 5 individual, 2 time sets
Platform:
GPL570
Series:
GSE58573
7 Samples
Download data: CEL

Supplemental Content

Recent activity

Your browsing activity is temporarily unavailable.

Support Center